How I treat my inflammatory bowel disease-patients with thiopurines?

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 4

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pharmacology and Therapeutics

ISSN

2150-5349

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastrointest Pharmacol Ther. Nov 6, 2016; 7(4): 524-530
Published online Nov 6, 2016. doi: 10.4292/wjgpt.v7.i4.524

Table 1 Laboratory tests to determine risk of myelotoxicity and hepatotoxicity during initiation of thiopurine therapy

Hematologic parameters

Hemoglobin

White blood cell count

Platelet count

Hepatic parameters

Alkalic phosphatase

Gamma glutamyl transpeptidase

Alanine aminotransferase

Other parameters

Creatinine

C-reactive protein

Measuring of above mentioned parameters: Induction phase: week 0, 1, 2, 4, 8 and 12; Maintenance phase: Each 3-4 mo.

Citation: Meijer B, Mulder CJ, van Bodegraven AA, de Boer NKH. How I treat my inflammatory bowel disease-patients with thiopurines? World J Gastrointest Pharmacol Ther 2016; 7(4): 524-530
URL: https://www.wjgnet.com/2150-5349/full/v7/i4/524.htm
DOI: https://dx.doi.org/10.4292/wjgpt.v7.i4.524

Meijer B, Mulder CJ, van Bodegraven AA, de Boer NKH. How I treat my inflammatory bowel disease-patients with thiopurines? World J Gastrointest Pharmacol Ther 2016; 7(4): 524-530 [PMID: 27867685 DOI: 10.4292/wjgpt.v7.i4.524]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.